← FDA DRUG APPROVALS

FDA ANDA · ANDA081043

PREDNISOLONE SODIUM PHOSPHATE

Sponsor: ALCON PHARMS LTD

APPLICATION
ANDA081043
TYPE
ANDA
ORIGINAL APPROVAL
1991-10-24
LATEST ACTION
1999-06-11
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

PREDNISOLONE SODIUM PHOSPHATEDiscontinued
PREDNISOLONE SODIUM PHOSPHATE EQ 0.11% PHOSPHATE · SOLUTION/DROPS · OPHTHALMIC

Approval history

1999-06-11Manufacturing (CMC) · Supplement 9AP
1999-02-19Manufacturing (CMC) · Supplement 7AP
1999-02-02Manufacturing (CMC) · Supplement 6AP
1996-12-04Manufacturing (CMC) · Supplement 5AP
1996-05-31Manufacturing (CMC) · Supplement 4AP
1996-04-16Manufacturing (CMC) · Supplement 3AP
1994-06-10Labeling · Supplement 1AP
1993-12-02Labeling · Supplement 2AP
1991-10-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →